Market Forecast By Prescription Type (Prescription Drugs, Over-the-Counter Drugs), By Drug Type (Branded Drugs, Generic Drugs, Branded Generic Drugs), By Drug Class (Small Molecules, Biologics, Biosimilars), By Indication (Cardiovascular Diseases, Immunology, Respiratory Diseases, Neurological Diseases, Infectious Diseases, Skin Diseases), By Mode of Administration (Topical, Oral, Injectable, Intra-nasal, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) And Competitive Landscape
| Product Code: ETC10081538 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
According to 6Wresearch internal database and industry insights
Below mentioned are the evaluation of year-wise growth rate along with key drivers:
| Years | Est. Annual Growth (%) | Growth Drivers |
| 2021 | 6.2 | Growth of public healthcare coverage and increasing requirements for essential medicines. |
| 2022 | 6.6 | Rising spread of generic and branded generic drugs across urban regions. |
| 2023 | 7.1 | Increasing occurrence of chronic and lifestyle-related diseases |
| 2024 | 7.6 | Rising in hospital infrastructure and pharmaceutical imports |
| 2025 | 8 | Government support for domestic drug manufacturing and healthcare advancement. |
The Vietnam Pharmaceutical Market report thoroughly covers the market by prescription type, drug type, drug class, indication, mode of administration, and distribution channel. It provides an unbiased and detailed analysis of ongoing market trends, opportunities, challenges, and market drivers, helping stakeholders align their strategies with current and future market dynamics.
| Report Name | Vietnam Pharmaceutical Market |
| Forecast period | 2026-2032 |
| CAGR | 8.3% |
| Growing Sector | Generic and Branded Generic Drugs |
Vietnam Pharmaceutical Market is predicted to undergo robust growth encouraged by increasing spendings on healthcare, rising knowledge of disease management, and growth of domestic pharmaceutical manufacturing. Increasing occurrence of cardiovascular, respiratory, and infectious diseases is raising long-term need for medicines. Increasing dependency on hospital pharmacies and retail drug stores is also contributing to Vietnam Pharmaceutical Market Growth.
Below mentioned are some prominent drivers and their influence on the Vietnam Pharmaceutical Market dynamics:
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising Healthcare Expenditure | All Segments | Higher spending improves medicine accessibility and treatment rates |
| Expansion of Domestic Manufacturing | Generic & Branded Generics | Local production reduces import dependency and improves affordability |
| Growing Chronic Disease Burden | Cardiovascular, Respiratory | Long-term treatment sustains pharmaceutical demand |
| Government Healthcare Reforms | All Segments | Policy support encourages industry growth and foreign participation |
| Urbanization & Population Growth | Retail Pharmacies | Increased medicine consumption in urban areas |
Vietnam Pharmaceutical Market size is projected to grow at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2032. Market growth is bolstered by increasing need for prescription medicines, growth of hospital infrastructure, and rising adoption of generic and branded generic drugs. Favourable government policies, augmented attainability to healthcare, and growing allocation of money by multinational pharmaceutical companies are augmenting Vietnam’s position as a major pharmaceutical market in Southeast Asia.
Below mentioned are some major restraints and their influence on the Vietnam Pharmaceutical Market dynamics:
| Restraints | Primary Segment Affected | What This Means (Evidence) |
| Regulatory Approval Delays | New Drug Launches | Long procedure of approval slow down the entry in the market and postpones the access to patients. |
| Price Controls | Pharmaceutical Companies | Restricts profit margins on essential medicines and limits the capacity of reinvestment. |
| Import Dependency | Biologics, Biosimilars | Dependency on imports impacts the supply consistency and raises price exposure. |
| Skilled Workforce Gap | R&D & Manufacturing | Bounds innovation and advanced development of drug while decreasing the speed of productivity |
| Distribution Inefficiencies | Rural Areas | Irregular access to medicines impacts the obtainability to treatment in remote regions |
Vietnam Pharmaceutical Industry goes through challenges consisting of regulatory complexity, costing pressures, reliability on imported biologics, and irregular distribution infrastructure. Companies should concentrate on compliance management, allocation of funds in local manufacturing, and growth of rural distribution chains to sustain long-term growth. Solidifying the skills of workforce and augmenting supply chain efficiency will also be important to overcome these challenges.
Several notable trends are shaping the Vietnam Pharmaceutical Market dynamics:
Some notable investment opportunities in the Vietnam Pharmaceutical Industry are:
Below is the list of prominent companies leading in the Vietnam Pharmaceutical Market:
| Company Name | DHG Pharma |
|---|---|
| Headquarters | Can Tho, Vietnam |
| Established | 1974 |
| Website | Click Here |
DHG Pharma is a major domestic manufacturer focused on branded generics and essential medicines across various therapeutic areas.
| Company Name | Traphaco Group |
|---|---|
| Headquarters | Hanoi, Vietnam |
| Established | 1972 |
| Website | - |
Traphaco has an expertise in herbal and generic pharmaceuticals, encouraging both retail and hospital demand. Its focusses on traditional medicine formulations strengthens its market differentiation.
| Company Name | Sanofi Vietnam |
|---|---|
| Headquarters | Ho Chi Minh City, Vietnam |
| Established | 1994 |
| Website | Click Here |
Sanofi Vietnam provides prescription medicines across cardiovascular and infectious disease segments. The company supports hospital treatment programs with consistent product supply.
| Company Name | Pfizer Vietnam |
|---|---|
| Headquarters | Ho Chi Minh City, Vietnam |
| Established | 2008 |
| Website | Click Here |
Pfizer Vietnam gives innovative therapies and vaccines supporting hospital-based treatments. Its worldwide research expertise enhances access to advanced pharmaceutical solutions.
| Company Name | Abbott Vietnam |
|---|---|
| Headquarters | Ho Chi Minh City, Vietnam |
| Established | 1995 |
| Website | Click Here |
Abbott Vietnam focusses on pharmaceuticals and healthcare products across chronic disease areas.
According to Vietnam’s government data, policies such as the National Pharmaceutical Development Strategy supports domestic drug manufacturing and technology transfer. Regulatory reforms encourages swift drug approvals, while public healthcare investment programs augment hospital procurement and medicine obtainability. These regulations also encourage foreign investment participation and solidifies quality standards across the pharmaceutical supply chain.
Vietnam Pharmaceutical Market is predicted to grow robustly encouraged by domestic manufacturing expansion, increasing demand of prescription drug, and healthcare infrastructure development. Rising allocation of funds in biologics, augmented regulatory efficiency, and growth of retail and online pharmacies will further solidify long-term market growth. Increasing concentration on cost-friendly medicines and broad rural healthcare coverage will also contribute to sustained pharmaceutical market growth.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Kapil, Senior Research Analyst, 6Wresearch, prescription drugs leads the Vietnam Pharmaceutical Market Share due to increasing occurrence of chronic disease and dependence on hospital-based treatment, supporting sustained demand. Rising physician-led therapies and regulatory oversight further strengthen prescription drug usage.
Branded generics lead due to cost-friendliness, physician trust, and robust domestic manufacturing presence and consistent quality standards and brand value solidifies the acceptance of patients.
Small molecules leads due to broad application across multiple therapeutic areas and cost efficiency and their well-established manufacturing procedures encourage large-scale production.
Cardiovascular treatments lead due to growing lifestyle-related health conditions requiring long-term medication and aging population trends further contribute to sustained demand in this segment.
Oral drugs leads due to ease of use, patient compliance, and broad prescription and increased availability across retail and hospital pharmacies encourages constant consumption.
Hospital pharmacies leads bolstered by increasing inpatient treatments and prescription drug procurement and growth of hospital infrastructure further encourages channel growth.
The report offers a comprehensive study of the following Vietnam Pharmaceutical Market segments:
| 1 Executive Summary |
| 2 Introduction |
| 2.1 Key Highlights of the Report |
| 2.2 Report Description |
| 2.3 Market Scope & Segmentation |
| 2.4 Research Methodology |
| 2.5 Assumptions |
| 3 Vietnam Pharmaceutical Market Overview |
| 3.1 Vietnam Country Macro Economic Indicators |
| 3.2 Vietnam Pharmaceutical Market Revenues & Volume, 2022 & 2032F |
| 3.3 Vietnam Pharmaceutical Market - Industry Life Cycle |
| 3.4 Vietnam Pharmaceutical Market - Porter's Five Forces |
| 3.5 Vietnam Pharmaceutical Market Revenues & Volume Share, By Prescription Type, 2022 & 2032F |
| 3.6 Vietnam Pharmaceutical Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
| 3.7 Vietnam Pharmaceutical Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
| 3.8 Vietnam Pharmaceutical Market Revenues & Volume Share, By Indication, 2022 & 2032F |
| 3.9 Vietnam Pharmaceutical Market Revenues & Volume Share, By Mode of Administration, 2022 & 2032F |
| 3.10 Vietnam Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
| 4 Vietnam Pharmaceutical Market Dynamics |
| 4.1 Impact Analysis |
| 4.2 Market Drivers |
| 4.2.1 Increasing healthcare expenditure in Vietnam |
| 4.2.2 Growth in the aging population leading to higher demand for pharmaceuticals |
| 4.2.3 Rising prevalence of chronic diseases requiring long-term medication |
| 4.3 Market Restraints |
| 4.3.1 Stringent regulatory environment for pharmaceutical products |
| 4.3.2 Limited access to healthcare services in rural areas |
| 4.3.3 Presence of counterfeit drugs impacting trust in the market |
| 5 Vietnam Pharmaceutical Market Trends |
| 6 Vietnam Pharmaceutical Market, By Types |
| 6.1 Vietnam Pharmaceutical Market, By Prescription Type |
| 6.1.1 Overview and Analysis |
| 6.1.2 Vietnam Pharmaceutical Market Revenues & Volume, By Prescription Type, 2022- 2032F |
| 6.1.3 Vietnam Pharmaceutical Market Revenues & Volume, By Prescription Drugs, 2022- 2032F |
| 6.1.4 Vietnam Pharmaceutical Market Revenues & Volume, By Over-the-Counter Drugs, 2022- 2032F |
| 6.2 Vietnam Pharmaceutical Market, By Drug Type |
| 6.2.1 Overview and Analysis |
| 6.2.2 Vietnam Pharmaceutical Market Revenues & Volume, By Branded Drugs, 2022- 2032F |
| 6.2.3 Vietnam Pharmaceutical Market Revenues & Volume, By Generic Drugs, 2022- 2032F |
| 6.2.4 Vietnam Pharmaceutical Market Revenues & Volume, By Branded Generic Drugs, 2022- 2032F |
| 6.3 Vietnam Pharmaceutical Market, By Drug Class |
| 6.3.1 Overview and Analysis |
| 6.3.2 Vietnam Pharmaceutical Market Revenues & Volume, By Small Molecules, 2022- 2032F |
| 6.3.3 Vietnam Pharmaceutical Market Revenues & Volume, By Biologics, 2022- 2032F |
| 6.3.4 Vietnam Pharmaceutical Market Revenues & Volume, By Biosimilars, 2022- 2032F |
| 6.4 Vietnam Pharmaceutical Market, By Indication |
| 6.4.1 Overview and Analysis |
| 6.4.2 Vietnam Pharmaceutical Market Revenues & Volume, By Cardiovascular Diseases, 2022- 2032F |
| 6.4.3 Vietnam Pharmaceutical Market Revenues & Volume, By Immunology, 2022- 2032F |
| 6.4.4 Vietnam Pharmaceutical Market Revenues & Volume, By Respiratory Diseases, 2022- 2032F |
| 6.4.5 Vietnam Pharmaceutical Market Revenues & Volume, By Neurological Diseases, 2022- 2032F |
| 6.4.6 Vietnam Pharmaceutical Market Revenues & Volume, By Infectious Diseases, 2022- 2032F |
| 6.4.7 Vietnam Pharmaceutical Market Revenues & Volume, By Skin Diseases, 2022- 2032F |
| 6.5 Vietnam Pharmaceutical Market, By Mode of Administration |
| 6.5.1 Overview and Analysis |
| 6.5.2 Vietnam Pharmaceutical Market Revenues & Volume, By Topical, 2022- 2032F |
| 6.5.3 Vietnam Pharmaceutical Market Revenues & Volume, By Oral, 2022- 2032F |
| 6.5.4 Vietnam Pharmaceutical Market Revenues & Volume, By Injectable, 2022- 2032F |
| 6.5.5 Vietnam Pharmaceutical Market Revenues & Volume, By Intra-nasal, 2022- 2032F |
| 6.5.6 Vietnam Pharmaceutical Market Revenues & Volume, By Others, 2022- 2032F |
| 6.6 Vietnam Pharmaceutical Market, By Distribution Channel |
| 6.6.1 Overview and Analysis |
| 6.6.2 Vietnam Pharmaceutical Market Revenues & Volume, By Hospital Pharmacies, 2022- 2032F |
| 6.6.3 Vietnam Pharmaceutical Market Revenues & Volume, By Retail Pharmacies, 2022- 2032F |
| 6.6.4 Vietnam Pharmaceutical Market Revenues & Volume, By Drug Stores, 2022- 2032F |
| 6.6.5 Vietnam Pharmaceutical Market Revenues & Volume, By Online Pharmacies, 2022- 2032F |
| 7 Vietnam Pharmaceutical Market Import-Export Trade Statistics |
| 7.1 Vietnam Pharmaceutical Market Export to Major Countries |
| 7.2 Vietnam Pharmaceutical Market Imports from Major Countries |
| 8 Vietnam Pharmaceutical Market Key Performance Indicators |
| 8.1 Number of new drug approvals by regulatory authorities |
| 8.2 Percentage of population covered by health insurance |
| 8.3 Investment in healthcare infrastructure and facilities |
| 8.4 Research and development expenditure in the pharmaceutical sector |
| 9 Vietnam Pharmaceutical Market - Opportunity Assessment |
| 9.1 Vietnam Pharmaceutical Market Opportunity Assessment, By Prescription Type, 2022 & 2032F |
| 9.2 Vietnam Pharmaceutical Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
| 9.3 Vietnam Pharmaceutical Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
| 9.4 Vietnam Pharmaceutical Market Opportunity Assessment, By Indication, 2022 & 2032F |
| 9.5 Vietnam Pharmaceutical Market Opportunity Assessment, By Mode of Administration, 2022 & 2032F |
| 9.6 Vietnam Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
| 10 Vietnam Pharmaceutical Market - Competitive Landscape |
| 10.1 Vietnam Pharmaceutical Market Revenue Share, By Companies, 2022 & 2032F |
| 10.2 Vietnam Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
| 11 Company Profiles |
| 12 Recommendations |
| 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here